Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:A Schwab Sales Vet Bets On a Specialty Indexer Not Rated 0.0 Email Routing List Email & Route  Print Print
Thursday, January 8, 2009

A Schwab Sales Vet Bets On a Specialty Indexer

Reported by Neil Anderson, Managing Editor

Jeff Carlin just joined IndexIQ. On Thursday the Rye Brook, New York-based alternatives indexer revealed that Carlin, formerly national sales at Schwab, climbed aboard as senior vice president and national sales manager, as part of a strategy to go after the RIA marketplace.

A spokesman for Schwab confirmed that Carlin had worked in the San Francisco-based firm's managed accounts group, yet the spokesman was not immediately able to comment on how Carlin's duties are being handled.

Tony Davidow, executive vice president and head of distribution at IndexIQ, praised Carlin for his "broad understanding of the investment needs of registered investment advisors and their clients."

"Going into 209, we expect to see significant interest from RIAs in our hedge fund replication products and other alternative investment strategies," Davidow stated. "Jeff is ideally suited to help grow IndexIQ's presence in this very important market."


Company Press Release

NEW YORK - (Business Wire) Jeff Carlin has been named Senior Vice President & National Sales Manager at IndexIQ (www.indexiq.com), a pioneer in the development of hedge fund replication and other innovative alternative investment strategies for the advisor market, it was announced today. Carlin joins the firm from the Charles Schwab Corporation, the leading provider of investment products and custody services to independent registered investment advisors (RIAs), where he was National Sales Manager.

“Jeff brings a broad understanding of the investment needs of registered investment advisors and their clients to his role here at IndexIQ,” said Tony Davidow, Executive Vice President & Head of Distribution at the firm. “Going into 2009, we expect to see significant interest from RIAs in our hedge fund replication products and other alternative investment strategies. With his broad-based industry experience, Jeff is ideally suited to help grow IndexIQ’s presence in this very important market.”

IndexIQ is a leading developer of innovative alternative investment products that combine the benefits of traditional index investing with the risk-adjusted performance potential sought by the best active managers. A pioneer in hedge fund replication, IndexIQ launched a full suite of investable index-based solutions in early 2007, and recently introduced the IQ Alpha Hedge Strategy Fund, the first no-load mutual fund that seeks to replicate hedge fund performance characteristics.* IndexIQ also has introduced the first suite of hedge fund replication SMA strategies targeted to High-Net-Worth Investors. In developing its product offerings, IndexIQ works closely with its Academic Board, comprised of some of the leading thinkers and researchers in portfolio construction, finance and alternative investments. The Academic Board is led by Professor Robert Whitelaw, Chairman of the Finance Department at NYU’s Stern School of Business and Chief Investment Strategist at IndexIQ.

“RIAs have been seeking an ‘alternative to alternatives’ that addresses the critical issues of transparency, liquidity, and cost,” said Carlin. “With its transparent structure, high degree of liquidity, and low cost, the IndexIQ suite of products provides a compelling new alternative investment option for advisors and their clients.”

Carlin has spent 15 years in the financial services industry, serving as a Regional Sales Director at Smith Barney’s Consulting Group prior to joining Schwab. He sits on the Board of Directors of the Investment Management Consultants Association (IMCA).

About IndexIQ

Based in Rye Brook, New York, IndexIQ is the leading developer of index-based alternative investment solutions that combine the benefits of traditional index investing with the risk-adjusted return potential sought by the best active managers. The company’s philosophy is to democratize investment management by making innovative alternative investment strategies available to all investors in low cost, liquid, transparent and tax-efficient products. IndexIQ strategies are marketed through the company’s proprietary investment products and select partnerships with leading global financial institutions.

Additional information about the company and its products can be found at www.indexiq.com.

*Investors are reminded that mutual fund investing involves risk, including possible loss of principal. The Fund and its index are new, with limited historical performance data. There are no guarantees that the Fund will meet its objective. The Fund should be considered a high-risk investment due to its use of leverage, short-selling and derivatives, all of which may amplify the volatility of the Fund's share price. An investor in the Fund will bear the operating expenses of the underlying ETFs and related securities in which the Fund invests.

While it is a no-load fund, other fees and charges do apply. The Fund's Investment Adviser has contractually agreed to waive fees or reimburse expenses so that the Fund's total annual operating expenses do not exceed 1.15%. The expense limitation ends on April 30, 2009, at which time the limitation may be renewed, terminated or revised. The Fund will also assess a 2.00% redemption fee on shares redeemed within 7 days of purchase.

Consider the Fund's investment objectives, risks, charges and expenses carefully before investing. A prospectus with this and other information about the Fund may be obtained by visiting www.indexiq.com or by calling (888) 934-0777. Read the prospectus carefully before investing.

The Fund is distributed by PFPC Distributors, Inc., which is not affiliated with IndexIQ or the IQ

ALPHA Hedge Strategy Fund's investment advisor, or with any of the individuals on the Academic Board. SMA strategies and other products are offered through IndexIQ Advisors LLC. 

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use